Otc - Active Ingredient
rehmannia root, angelica gigas root, akebia stem, scutellaria root, alisma rhizome, plantago seed, licorice, gardenia fruit, gentian root and rhizome, cinnamomum cassia presl, raw ginger, rhubarb, ephdra heab, forsythia fruit
Yobisin Tablet
FDA Label NDC 72988-0012
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Lydia Co., Ltd. for the product Yobisin (NDC 72988-0012). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
magnesium stearate, corn starch, polyethylene glycol 6000, hypromellose 2910
Otc - Purpose
bladder qatar, urethritis, kidney disease, nephrotic syndrome, edema
Otc - Keep Out Of Reach Of Children
keep out of reach of the children
Indications & Usage
adults: 3~6 tablets twice a day
7 to 14 years old: 2-3 tablets twice a day
Warnings
do not take this medicine if you have following symptoms
children under 6 years old
women who are likely to be pregnant or pregnant
breastfeeding
Dosage & Administration
for oral use only
Package Label.Principal Display Panel
Label (Label)
* Please review the disclaimer below.
